SEARCHCASE_REPORTpediatrics, gastroenterology

case_report·pediatrics, gastroenterology, nutrition, clinical nutrition·PMC10311743

Efficacy of Crohn’s disease exclusion diet in treatment -naïve children and children progressed on biological therapy: a retrospective chart review

BMC Gastroenterology · 8 authors, 1 centre

AI SUMMARY

FIDELITY 100%

This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.

AGENT 01 · STRUCTURED SUMMARY

TRACE TO SOURCE

“

TL;DR

This retrospective chart review of 15 children with Crohn's disease found that the Crohn's disease exclusion diet plus partial enteral nutrition (CDED plus PEN) achieved 100% clinical remission at week 6 in both treatment-naïve patients (group A) and those who lost response to biologics (group B), with sustained remission at week 24 in 87% and 60% of patients, respectively.

Full summary

611 CHARS

At week 24, 87% of group A and 60% of group B maintained remission. In group A, faecal calprotectin and albumin improved significantly at weeks 6, 12, and 24; ESR improved at weeks 12 and 24; haemoglobin and iron improved at week 24. Group B showed only non-significant numerical reductions in faecal calprotectin and PCDAI. Adherence was excellent and no adverse events were reported in either group. Limitations include the small sample size, single-centre retrospective design, absence of a concurrent control group, reliance on clinical notes for adherence assessment, and lack of endoscopic follow-up data.

STUDY TYPE

case_report

SPECIALTY

pediatrics

SUMMARISED BY

AI pipeline

FIDELITY CHECK

100% · A

ORIGINAL PAPER

PMC10311743

Efficacy of Crohn’s disease exclusion diet in treatment -naïve children and children progressed on biological therapy: a retrospective chart review

BMC Gastroenterology

READ THE FULL PAPER

ABSTRACT

Background Recent trials suggested that the Crohn’s disease (CD) exclusion diet (CDED) plus partial enteral nutrition (PEN) is a safe and effective strategy in remission induction of paediatric-onset CD. However, real-world evidence regarding the safety and efficacy of the CDED plus PEN approach is still lacking. The present case-series study reported our experience with the outcomes of CDED plus PEN in the paediatric-onset CD at disease onset and after the loss of response to biologics. Methods We conducted a retrospective chart review on children who were treated with CDED plus PEN through the period from July 2019 and December 2020. Clinical and laboratory data were retrieved and compared at baseline, 6, 12, and 24 weeks of treatment. The primary endpoint of the present study was the rate of clinical remission. Results The present study retrieved the data from 15 patients. Of them, nine patients were treatment naïve at the time of initiation of CDED plus PEN (group A) and the remaining patients relapsed on biologics before treatment. All patients in groups A and B exhibited clinical remission in week six, which was sustained until week 12. At the end of the follow-up, the clinical remission rate was 87% and 60% in groups A and B, respectively. No side effects were observed in both groups. In group A, the faecal calprotectin (FC) and albumin improved at week six, week 12, and week 24 (p < 0.05). The erythrocyte sedimentation rate (ESR) improved significantly at week 12 (p = 0.021) and week 24 (p = 0.027). At the same time, the haemoglobin and iron levels showed significant improvement only at week 24. For group B, only FC showed numerical reductions over time that did not reach the level of statistical significance. Conclusion Treatment with CDED plus PEN was well tolerated and achieved an excellent clinical remission rate in treatment-naive patients. However, the benefit of CDED plus PEN was less in patients who initiated the strategy after losing the response to biologics.

CITATION EXPORT

María Clara Jijón Andrade, Gemma Pujol Muncunill, Ana Lozano Ruf et al.. Efficacy of Crohn’s disease exclusion diet in treatment -naïve children and children progressed on biological therapy: a retrospective chart review. BMC Gastroenterology. (2023). https://doi.org/10.1186/s12876-023-02857-6

AUTHORS

8 · 1 CENTRES

María Clara Jijón Andrade, Gemma Pujol Muncunill, Ana Lozano Ruf, Laura Álvarez Carnero, Victor Vila Miravet, Dolores García Arenas, Natalia Egea Castillo, Javier Martín de Carpi

Unit for the Comprehensive Care of Paediatric IBD, Department of Paediatric Gastroenterology, Hepatology and Nutrition, Sant Joan de Déu Hospital, Barcelona, Spain